{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:42:25Z","timestamp":1782564145554,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T00:00:00Z","timestamp":1350345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00198-012-2184-6","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T21:38:44Z","timestamp":1350509924000},"page":"321-328","source":"Crossref","is-referenced-by-count":21,"title":["Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study"],"prefix":"10.1007","volume":"24","author":[{"given":"B.","family":"Abrahamsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"2184_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/JBMR.050104","volume":"20","author":"MC Hochberg","year":"2005","unstructured":"Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P et al (2005) Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20:971\u2013976","journal-title":"J Bone Miner Res"},{"key":"2184_CR2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"2184_CR3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"2184_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1185\/03007990802645461","volume":"25","author":"D Hosking","year":"2009","unstructured":"Hosking D, Alonso CG, Brandi ML (2009) Management of osteoporosis with PTH: treatment and prescription patterns in Europe. Current Med Res Opin 25:263\u2013270. doi: 10.1185\/03007990802645461","journal-title":"Current Med Res Opin"},{"key":"2184_CR5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/jama.2009.1409","volume":"302","author":"FM Clement","year":"2009","unstructured":"Clement FM, Harris A, Yong K, Lee KM, Manns BJ (2009) Using effectiveness and cost-effectiveness to make drug coverage decisions. JAMA 302:1437\u20131443","journal-title":"JAMA"},{"key":"2184_CR6","doi-asserted-by":"crossref","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? JBMR. doi: 10.1002\/jbmr.1582","DOI":"10.1002\/jbmr.1582"},{"key":"2184_CR7","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077\u20132082","journal-title":"JAMA"},{"key":"2184_CR8","doi-asserted-by":"crossref","unstructured":"Inderjeeth CA, Chan K, Kwan K, Lai M (2012) Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments. J Bone Miner Metab. doi: 10.1007\/s00774-012-0349-1","DOI":"10.1007\/s00774-012-0349-1"},{"key":"2184_CR9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139","journal-title":"Med Care"},{"key":"2184_CR10","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2008-2765","volume":"94","author":"R Eastell","year":"2009","unstructured":"Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K et al (2009) Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab 94:3215\u20133225","journal-title":"J Clin Endocrinol Metab"},{"key":"2184_CR11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/jbmr.342","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Vrijens B, Cahall DL, Ringe JD, Garnero P, Watts NB (2011) Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. J Bone Min Res: Off J Am Soc Bone Min Res 26:1662\u20131669. doi: 10.1002\/jbmr.342","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"key":"2184_CR12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108\u20131112","journal-title":"Arch Intern Med"},{"key":"2184_CR13","unstructured":"Rejnmark L, Abrahamsen B, Ejersted C, Hyldstrup L, Jensen J-EB, Madsen OR, et al. The Danish Bone Society Osteoporosis Diagnosis and Treatment Guideline. Aarhus. 2009 Available: http:\/\/www.dkms.dk\/vejledning\/11_glukokort.htm . Accessed 16 Jun 2012"},{"key":"2184_CR14","doi-asserted-by":"crossref","unstructured":"Rizzoli R, Cooper C, Reginster J-Y, Abrahamsen B, Adachi JD, Brandi ML et al (2012) Antidepressant medications and osteoporosis. Bone. doi: 10.1016\/j.bone.2012.05.018","DOI":"10.1016\/j.bone.2012.05.018"},{"key":"2184_CR15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00198-008-0711-2","volume":"20","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen B, Brixen K (2009) Mapping the prescriptiome to fractures in men\u2013a national analysis of prescription history and fracture risk. Osteoporos Int 20:585\u2013597","journal-title":"Osteoporos Int"},{"key":"2184_CR16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","volume":"27","author":"C-S Eom","year":"2012","unstructured":"Eom C-S, Lee H-K, Ye S, Park SM, Cho K-H (2012) Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. JBMR 27:1186\u20131195. doi: 10.1002\/jbmr.1554","journal-title":"JBMR"},{"key":"2184_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00223-007-9099-9","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008) Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 82:92\u2013101","journal-title":"Calcif Tissue Int"},{"key":"2184_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","volume":"81","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81:153\u2013161","journal-title":"Calcif Tissue Int"},{"key":"2184_CR19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1532-5415.2005.53464.x","volume":"53","author":"HA Fink","year":"2005","unstructured":"Fink HA, Kuskowski MA, Orwoll ES, Cauley JA, Ensrud KE (2005) Association between Parkinson\u2019s disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 53:1559\u20131564","journal-title":"J Am Geriatr Soc"},{"key":"2184_CR20","doi-asserted-by":"crossref","unstructured":"Abrahamsen B, Eiken P, Eastell R (2011) Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med","DOI":"10.1001\/archinternmed.2011.20"},{"key":"2184_CR21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10620-005-2651-4","volume":"50","author":"N Figura","year":"2005","unstructured":"Figura N, Gennari L, Merlotti D, Lenzi C, Campagna S, Franci B et al (2005) Prevalence of helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci 50:847\u2013852","journal-title":"Dig Dis Sci"},{"key":"2184_CR22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jbmr.5650070514","volume":"7","author":"JB Goerss","year":"1992","unstructured":"Goerss JB, Kim CH, Atkinson EJ, Eastell R, O\u2019Fallon WM, Melton LJ III (1992) Risk of fractures in patients with pernicious anemia. J Bone Miner Res 7:573\u2013579","journal-title":"J Bone Miner Res"},{"key":"2184_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","volume":"58","author":"SD Berry","year":"2010","unstructured":"Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58:783\u2013787. doi: 10.1111\/j.1532-5415.2010.02767.x","journal-title":"J Am Geriatr Soc"},{"key":"2184_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","volume":"76","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167\u2013175","journal-title":"Calcif Tissue Int"},{"key":"2184_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2362.2003.01103.x","volume":"33","author":"L Rejnmark","year":"2003","unstructured":"Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (2003) Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 33:41\u201350","journal-title":"Eur J Clin Invest"},{"key":"2184_CR26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jama.2011.176","volume":"305","author":"SA Jamal","year":"2011","unstructured":"Jamal SA, Hamilton CJ, Eastell R, Cummings SR (2011) Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. JAMA 305:800\u2013807","journal-title":"JAMA"},{"key":"2184_CR27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1359\/jbmr.060804","volume":"21","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 21:1811\u20131817","journal-title":"J Bone Miner Res"},{"key":"2184_CR28","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/jc.2009-2342","volume":"95","author":"S Pouwels","year":"2010","unstructured":"Pouwels S, Lalmohamed A, van Staa T, Cooper C, Souverein P, Leufkens HG et al (2010) Use of organic nitrates and the risk of hip fracture: a population-based case-control study. J Clin Endocrinol Metab 95:1924\u20131931. doi: 10.1210\/jc.2009-2342","journal-title":"J Clin Endocrinol Metab"},{"key":"2184_CR29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","volume":"49","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T et al (2011) International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 49:1271\u20131274","journal-title":"Clin Chem Lab Med"},{"key":"2184_CR30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"2184_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.maturitas.2010.09.002","volume":"67","author":"TACM Laurs-van Geel","year":"2010","unstructured":"Laurs-van Geel TACM, Center JR, Geusens PP, Dinant G-J, Eisman JA (2010) Clinical fractures cluster in time after initial fracture. Maturitas 67:339\u2013342. doi: 10.1016\/j.maturitas.2010.09.002","journal-title":"Maturitas"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2184-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2184-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:50Z","timestamp":1558624130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2184-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2184"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2184-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}